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Infertility is one of the most serious social problems facing advanced nations. In general, approximate half of all cases of infertility
are caused by factors related to the male partner. To date, various treatments have been developed for male infertility and are
steadily producing results. However, there is no eﬀective treatment for patients with nonobstructive azoospermia, in which
there is an absence of mature sperm in the testes. Although evidence suggests that many patients with male infertility have a
genetic predisposition to the condition, the cause has not been elucidated in the vast majority of cases. This paper discusses the
environmental factors considered likely to be involved in male infertility and the genes that have been clearly shown to be involved
in male infertility in humans, including our recent ﬁndings.
1.Introduction
One of the most serious social problems facing developed
countries today is the declining birth rate, although it is
generally not well recognized that the number of infertile
couples is on the rise in these countries. While both social
(i.e., social progress for women and the resulting increase
in the age at which women marry) and environmental (i.e.,
pollution and global warming) factors are behind part of the
increase in the number of patients with infertility, infertility
in the male partner contributes to approximately half of all
cases.
To date, various techniques, such as in vitro fertilization
(particularly, intracytoplasmic sperm injection or ICSI)
and so-called TESE-ICSI involving the harvesting of sperm
from the testes, have been developed for male infertility.
Although these methods are steadily producing results, no
technique has proven eﬀective for patients with nonob-
structive azoospermia, in which there is an absence of
mature sperm in the testes. Evidence suggests that many
patients with azoospermia have a genetic predisposition to
the condition, although the cause has not been elucidated
in the vast majority of cases [1]. Conversely, studies using
knockout mouse models have recently linked many genes
to spermatogenesis, the mechanisms of which are currently
being clariﬁed.
These animal ﬁndings have yet to be shown applicable to
most human cases. This is because identifying the aﬀected
g e n e si nh u m a n sr e q u i r e sar e t r o g r a d eg e n e t i ca p p r o a c h
and because the knockout mouse phenotype is not always
faithfully reproduced in humans. This paper discusses the
environmental factors considered likely to be involved in
male infertility and the genes that have been clearly shown
to be involved in male infertility in humans, including our
recent research ﬁndings.
2. Human Male Infertilityand
EnvironmentalFactors
There has long been debate over whether male reproductive
ability is determined by environmental factors, such as those2 Advances in Urology
present in the workplace or area of residence. Having a
major eﬀect on this debate was the sensational report by
Whorton et al. published in 1977, which found that of 25
maleworkersinvolvedinproducingtheinsecticidedibromo-
3-chloropropane(DBCP),14werediagnosedasazoospermic
or oligospermic [2]. In 1992, Carlsen et al. reported that the
previous 50 years saw a marked decrease in sperm count [3].
That same year, Brake and Krause reported that during the
period since 1970 in Scotland, sperm counts had decreased
by approximately 25% compared with the period prior to
1959, a mean annual rate of 2.1% [4].
Many researchers and clinicians have asserted that soci-
etal progress in advanced countries and worsening of the
natural environment have likely resulted in decreased male
fertility. Long-reported risk factors include working in high
temperatures [5], noise associated with manufacturing [6],
exposure to radiation [7], electromagnetic waves [8], and a
variety of chemical substances [9]. Numerous studies have
compared patients with male infertility (oligospermia or
azoospermia) to healthy subjects (normal sperm count). To
date, proposed risk factors include air temperature [10],
automobile driving time per day [11], air pollution [12],
regional diﬀerences in residential population density [13],
mumps [14], stress [15], and alcoholism [16]. On the
contrary, many reports indicate the absence of a correlation
between environmental factors and male infertility [17, 18].
Thus, there is presently no consistent view on the role of
environmental factors and male infertility.
Onereasonforthesediscrepanciesisthatthesamplesizes
have been insuﬃcient to determine statistically signiﬁcant
diﬀerences.Thetotalnumberofpatientswithmaleinfertility
included in these studies has been small, fewer than 100
patientsinnearlyallcases.Anotherreasonisthatnearlyallof
these studies have been survey studies using questionnaires,
with no objective tests like measuring blood concentrations.
Consequently, levels of exposure have been very ambiguous,
and selecting healthy men as controls has been problematic.
Many recent studies have included a control group
consisting of healthy men selected based on semen ﬁndings.
However, nearly all of these have been patients who desired
to have children and had been examined for infertility on
an outpatient basis. Thus, even if the semen ﬁndings were
normal, it is highly questionable whether the male partner
of an infertile couple can be considered healthy. To further
elucidatetherelationshipbetweenenvironmentalfactorsand
male infertility, future studies should incorporate a larger
cohort and an appropriate selection of healthy male controls.
3. Human Azoospermia andthe Y Chromosome
In 1976, Tiepolo and Zuﬀardi ﬁrst proposed an explanation
for the role of the human Y chromosome in spermatoge-
nesis [19]. They microscopically identiﬁed the presence of
microdeletions on the long arm of the Y chromosome in
six patients with azoospermia and proposed an important
spermatogenesis gene in this region. They named this the
azoospermia factor (AZF) region. Various subsequent stud-
ies have been conducted, particularly by Vogt et al. [20], and
in 1995, Reijo et al. examined 89 patients with nonobstruc-
tive azoospermia and found that 12 (13%) had a deletion
in the AZF region. These results brought recognition to
the close relationship between human azoospermia and this
region [21]. Vogt et al. further showed the microdeletions to
be concentrated in three regions according to the testicular
tissue type and divided the AZF region into subregions,
AZFa, AZFb, and AZFb [22].
4. Azoospermia Culprit Gene Groups
4.1. Culprit Gene Identiﬁed in the AZF Region. In 1995, Reijo
etal.isolatedthehumandeleted-in-azoospermia(DAZ)gene
[21]. The human DAZ gene is localized to the AZFc region
and encodes 366 amino acids. Its expression is speciﬁc to the
testis, and the amino acids it encodes have a characteristic
structure consisting of an RNP/RRM domain with an RNA
binding function and seven tandem repeats of 72 bases
[23, 24]. The DAZ gene was the ﬁrst culprit gene identiﬁed
as causing human azoospermia as a result of gene mutation.
This came 19 years after Tiepolo and Zuﬀardi ﬁrst proposed
the concept of the AZF region in 1976. This discovery
triggered worldwide advances in the search for culprit genes
in human azoospermia, and even today this gene is widely
known as the most representative of the human azoospermia
culprit genes.
Two years later, in 1997, Elliot et al. reported a second
azoospermia culprit gene, the RNA-binding motif gene
(RBMY, Y chromosome) [25]. As its name suggests, the
RBMY gene, like DAZ, encodes an RNA-binding protein; it
is located in the AZFb region. The RBMY gene is speciﬁcally
expressed in germ cells in fetal, adolescent, and adult testes.
It is not expressed in somatic cells, such as Sertoli cells. With
a deﬁciency of RBMY, germ cell diﬀerentiation is observed
onlyuntilearlymeiosis[25].Theseresearchﬁndingsstrongly
suggest that RBMY plays an important role in the process of
human spermatogenesis.
In 1999, two years after the report by Elliot et al., Sun
et al. identiﬁed a new human spermatogenesis gene, USP9Y
(DFFRY), in the AZFa region [26]. Using DNA from a
total of 576 patients with nonobstructive azoospermia or
severe oligospermia (sperm count ≤ 5 million/mL) and 96
healthy subjects, the group performed analysis of single-
strand conformation polymorphisms and sequence analysis
and identiﬁed a 4-bp deletion at the splice-donor site of
intron 7 in one patient. Due to this deletion, exon 7 was not
expressed at the RNA level, and a frame shift had occurred in
this patient, resulting in the loss of approximately 90% of the
proteins that would normally have been encoded.
4.2. Culprit Gene Identiﬁed in Autosomes. The three genes
mentioned above are typical spermatogenesis genes localized
to the AZF region on the Y chromosome. Many clinicians
and researchers have analyzed this region. However, analysis
using knockout mice showed numerous autosomal mouse
spermatogenesis genes and the importance of meiosis, which
is indispensable for the process of spermatogenesis, in
the formation of ova. Consequently, we proceeded ourAdvances in Urology 3
analyses based on the hypothesis that culprit genes in human
azoospermia are also present in autosomes.
In 2000, Yuan et al. reported a Sycp3 (Scp 3) gene knock-
out mouse [27]. Synaptonemal complex protein 3 (SYCP3)
is a DNA-binding protein related to the synapses involved
in the process of germ cell meiosis [28–30]. Both male
and female Scycp3 knockout mice develop normally, while
the homomutant male has no reproductive potential. The
knockout mouse has markedly smaller testis, and histologic
analysis indicates meiotic arrest, with a complete absence
of round spermatid and elongated spermatid cells, which
typically appear after meiosis. Moreover, the mouse has no
mature sperm [27]. Compared with wild type, the female
Sycp3 gene knockout mouse produces fewer oﬀspring, even
though it is capable of gestation and parturition [27]; further
analysis has shown the cause to be fetal death in utero due to
a chromosomal aberration. The frequency of in utero fetal
death increases with the age of the mouse [31]. Based on
these ﬁndings in mice, we hypothesized that the SYCP3 gene
plays an important role in human spermatogenesis.
To examine our hypothesis, we ﬁrst established a primer
for the site of the human genome sequence homologous to
the mouse Sycp3 cDNA at the amino acid level and then
used a human testicular cDNA library to isolate human
SYCP3 cDNA. The human SYCP3 gene is composed of nine
exons and is located on chromosome 12. Its expression is
speciﬁc to the testis. It encodes 236 amino acids and has two
coiled-coil domains [32]. Mutation analysis was performed
for all of the coding regions and adjacent introns in 19
patients with azoospermia diagnosed as being caused by a
meiotic anomaly, based on histologic analysis. We detected
a heterozygous deletion of one adenosine base at the 643-
nt site in two of the 19 patients. To rule out polymorphism,
we also performed sequence analysis using DNA from 75
healthy men and conﬁrmed no mutations in any of these
subjects (P = 0.039). Upon repeating detailed histologic
analysis, obvious meiotic arrest was observed in the two
patients with this mutation. As a result of the loss of germ
cells in these patients, a clear decrease in the diameter of the
seminiferous tubules and vacuole formation in the testis was
seen. Moreover, no round haploid spermatids, elongating
spermatids, or mature sperm were seen. These histologic
ﬁndings are consistent with those for the knockout mouse
[27].
A coiled-coil domain present in three regions of the rat
Sycp3 gene has been known to play an important role in
protein binding [33]. We detected a deletion in this coiled-
coil domain. The mutation results in a frame shift, and
an early stop codon appears, resulting in an incomplete
domain. Consequently, we performed functional analysis of
the mutation, by amplifying the sequence associated with
the single base deletion at the 643-nt site and normal cDNA
usingPCRandtheninsertingthemintoanexpressionvector.
Followingproteinextraction,aproteinbinding assayshowed
that in patients with the mutation, the SYCP3 gene had lost
its protein binding capacity [32]. Based on these ﬁndings, we
succeeded for the ﬁrst time in identifying the azoospermia
culprit gene SYCP3 located outside the AZF region of the Y
chromosome (human chromosome 12).
In 2006, Yatsenko et al. carried out a novel diagnostic
strategy using mRNA transcripts from mature sperm in
the semen ejaculate [34]. They showed that multiple full-
length spermatozoa mRNA that encode candidate infertility-
associated proteins can be eﬃciently screened for muta-
tions by reverse transcriptase-polymerase chain reaction
and demonstrated the utility of this approach to diagnose
unrecognized genetic defects in severely oligozoospermic
men. To test the eﬃciency of their protocol, they ampli-
ﬁed seven genes known to be pre- and/or postmeiotically
expressed in germ cells; all were previously characterized
using mouse models, and one of them was the kelch-
like 10 (KLHL10) gene; they previously demonstrated that
haploinsuﬃciency for Klh10 causes male infertility in mice
due to a severe decrease in elongated spermatids and
epididymal spermatozoa [35]. The human KLHL10 protein
is highly conserved in mammals and consists of 614 amino
acids having an N-terminal BTB (bric-a-brac, tramtrack,
broad-complex) domain and six tandem C-terminal kelch
repeats with an intervening BACK (BTB and C-terminal
kelch) domain. The BTB domain of KLHL10 has been
suggested to interact with cullin 3 (CUL3) to form a
CUL-KLHL10 ubiquitin E3 ligase complex [36] that acts
to mediate protein ubiquitination during spermatogenesis.
By analyzing KLHL10, they showed the feasibility of an
RNA-based approach in diagnosing genetic defects in the
germline of infertile men. Their analysis of sperm RNA
in 556 oligospermic and 394 normozoospermic individuals
revealed seven (1.3%) missense and splicing mutations in
thisevolutionarilyconserved,spermatid-expressedgene.The
A313T mutation aﬀects the kelch domain of the protein
believed to interact with substrate proteins destined for
26S proteasomal degradation. The Q216P mutation aﬀects
the BACK domain thought to orient the substrate in a
complex. Since both alleles impair homodimerization of
KLHL10 and presumably cause dimer instability, deﬁciency
of protein function may be either due to a dominant-
negativeeﬀectorduetodecreasedlevelsoffunctionaldimers
[34].
In 2007, Dieterich et al. reported that homozygous
mutation of the human aurora kinase C (AURKC)g e n e
yields large-headed polyploidy spermatozoa and causes male
infertility in humans [37]. They performed a genome-
wide microsatellite scan on ten infertile men presenting
a large-headed sperm phenotype. In all of these men, a
common region of homozygosity harbors the AURKC gene
with a single nucleotide deletion in exon 3 (c.144delC)
in the AURKC coding sequence. This mutation results in
premature termination of translation, yielding a truncated
protein that lacks the kinase domain. The absence of AURKC
causes male infertility owing to the production of large-
headed multiﬂagellar polyploidy spermatozoa. Using Aurkc
null mice [38], homozygous mice were shown to have
no apparent somatic defect and both male and female
heterozygous mice to have normal fertility. Moreover, no
reduced fecundity was reported in homozygous females,
whereas 40% of homozygous males failed to produce pups.
Globozoospermia is a rare (incidence <0.1% in male
infertile patients) but severe teratozoospermia, characterized4 Advances in Urology
byejaculatesconsistingcompletelyofround-headedsperma-
tozoathatlackacrosomes[39].Itoriginates fromadisturbed
spermatogenesis, and although the underlying cause is still
unknown, a genetic contribution appears to be supported by
several familial case reports [40–42] and by three recessive
mouse models involving CSNK2A2, HRB,a n dGOPC [43–
45]. Dam et al. investigated an Ashkenazi Jewish family with
sixbrothers(threeaﬀectedandthreehealthy)andfoursisters
[46]. A genome-wide scan analysis of all six brothers was
performed using 10K SNP array. There were approximate 50
knowngenesintheidentiﬁedregion,chromosome3q26.The
SPATA16 gene (spermatogenesis-associated 16, also known
as NYD-SP12) was selected as the most plausible candidate
gene, because it is expressed speciﬁcally in human testis, as
wellasprimarily inthemousespermatocytesandspermatids
[47]. SPATA16 is composed of 11 exons encoding a highly
conserved protein of 65kDa (599 aa), which contains a
tetratricopeptide repeat (TPR) domain; conservation is very
high (92% and 98% in mouse and chimpanzee, resp.)
for the TPR domain, a protein-protein interaction domain
commonly but exclusively found in cochaperone proteins.
Sequence analysis of one of the aﬀected sons revealed a
homozygous sequence variation in exon 4 (c.848G→A). The
three aﬀected brothers are homozygous, and the two parents
and two healthy brothers are heterozygous for the mutation;
the third unaﬀected brother appeared to be homozygous for
the wild-type sequence. The mutation is predicted to change
an amino acid of a highly conserved residue (p.R283Q)
located at the C-terminal end of the highly conserved TPR
domain.Inaddition,thec.848G→Amutationaﬀectsthelast
nucleotide of exon 4 and disrupts the 5  splice site of intron
4. Thus, the c.848G→A mutation leads to inappropriate
splicing of exon 4 that causes disruption of the TPR domain.
5. Male Infertilityand GeneticPolymorphism
Genetic polymorphisms may also increase susceptibil-
ity to some forms of male infertility. We have identi-
ﬁed polymorphisms of several genes that are associated
with the human azoospermic population—MEI1, PRDM9
(MEISETZ), SPATA17, PARP-2,a n dUBR2 genes are genetic
risk factors for the patients with azoospermia by meiotic
arrest [48–52], and polymorphisms of the SEPTIN12 gene
are associated with patients with Sertoli cell-only syndrome
[53]. Genetic polymorphisms and male infertility have been
under much investigation recently. Some genes identiﬁed to
be associated with male infertility in the past three years
include: MTHFR, SHBG, Piwi, CYP19A1, NER, GSTM1,
BCL2, ESR1, ESR2, eNOS, TNP1, SOHLH1, EPPIN, GSTT1,
TSSK6, TSSK2, MDR1, MSH5, MLH3, H2BFWT, PACRG,
and FASLG [54–74]. Despite identiﬁcation of these genes,
neither the mechanisms of human spermatogenesis nor the
association of these genes with each other is well known. We
believe that environment is an important factor associated
with genetic polymorphisms in human spermatogenesis.
Further analysis is thus strongly needed to determine the
association between genetic polymorphisms and environ-
mental factors.
6. Conclusion
Thispaperdiscussedthegenegroupsthathavebeenreported
to date to play a role in human spermatogenesis, as well as
our recent research ﬁndings. Recent mouse studies and our
geneticpolymorphismstudiessuggestthatnumeroushuman
spermatogenesis gene groups are present in regions other
thantheAZFregionoftheYchromosome,forwhichanalysis
has progressed worldwide. As patients with a microdeletion
in the AZF region of the Y chromosome account for approx-
imately 13% of those with human azoospermia (recent
reportsindicateanevenlowerpercentofapproximately7%),
new human azoospermia culprit genes are expected to be
identiﬁed in areas other than the Y chromosome.
Although striking progress has been achieved in recent
years in elucidating the mechanism of spermatogenesis using
knockout mice, few studies have applied these ﬁndings to
humans. A reason for this is the limitation of reproducing
the knockout mouse phenotype faithfully in humans.
When couples with a desire to have children visit our
hospital (Asahikawa Medical College Hospital) to examine
for infertility and the man is diagnosed as azoospermic
based on a semen test, a urologist will perform further
examinations such as endocrinology tests of the man,
testicular ultrasound, and chromosome tests (particularly,
determination of the presence of microdeletions in the AZF
region of the Y chromosome). Although the presence of
sperm in the testes can to some extent be determined based
on the results of these tests, a true determination can only be
madewhentesticularspermextractionisperformed.Further
research on human spermatogenesis is necessary to establish
a diagnostic method that is less invasive and that reduces the
mental, physical, and ﬁnancial burden on the patient.
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